#Harvoni

Nevertheless, researchers advise careful kidney monitoring when pairing the medications.

In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.

A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

In a recent small study of HIV-positive men who had recently contracted hepatitis C, Harvoni had a perfect cure rate.

Ending the epidemic is going to require addressing the fact that certain individuals are at high risk of reinfection after a cure.

These include a low CD4 count, having cirrhosis and taking certain hep C drug regimens.

In a recent small study of HIV-positive men who had recently contracted hepatitis C, Harvoni had a perfect cure rate.

Researchers identified this association after looking at real-world data on a large group of German individuals with HIV and hep C.

Such generic drugs could save nations huge sums in the coming years.

Hepatitis C advocate Peter McLoyd transformed his bad times into good ones.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.

Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.

Six weeks of Harvoni cured all acute hep C infections in HIV-positive people with HCV viral loads below 7 million in a recent small trial.

The FDA has approved Gilead Sciences’ Harvoni to treat the virus for genotypes 4, 5 or 6 of hep C, and in those coinfected with HIV.